Theramir Ltd

📍 Limassol, Cyprus🗓 Founded 2016👥 7 employees💰 Last funded Feb 2018
Biotechnology Research🌐 theramir.com
Website LinkedIn
Theramir’s proprietary technologies are based on microRNAs (miRNAs), a class of small non-coding RNAs that can regulate multiple genes and pathways associated with cancer growth and metastasis. The company has developed a panel of miRNAs, both biological and synthetic, which can affect the function and disrupt expression of an expanding list of oncoproteins that are dysregulated in most cancer types. Thus, our technologies can be applied to the development of novel targeted therapeutics that may potentially transform the precision oncology field by creating new knowledge on the pathology of the disease and by enabling the customization and personalization of cancer treatment.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Arab Emirates
1
Frequently asked questions
Who invested in Theramir Ltd?
Theramir Ltd has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Theramir Ltd last raise funding?
The most recent investment in Theramir Ltd recorded on gritt.io was in February 2018.
When was Theramir Ltd founded?
Theramir Ltd was founded in 2016.
What industry is Theramir Ltd in?
Theramir Ltd operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Theramir Ltd based?
Theramir Ltd is headquartered in Limassol, Cyprus.